Their studies confirm that variants in multiple enhancers within FTO obesity-associated regions regulate the expression of multiple genes (IRX3 and IRX5) in at least two obesity-relevant tissues (adipose and brain). The gene discussed is IRX5; the disease is obesity disorder.